Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the production of serotonin receptor agonists and antagonists. Its structure supports the formation of complex alkaloid-based drugs, especially those targeting neurological and psychiatric disorders such as migraines, depression, and anxiety. The compound's stereochemistry is critical for biological activity, making it valuable in asymmetric synthesis for drug development. It is also employed in the preparation of tryptamine-derived medicinal agents where precise three-dimensional orientation is required for receptor binding.